St. Jude Medical Inc. (STJ) announced the acquisition of Endosense SA, a Switzerland-based medical technology company focused on improving the efficacy, safety and accessibility of catheter ablation for the treatment of cardiac arrhythmias. St. Jude Medical has made an initial payment of approximately $170 million, and acquired 100 percent of the outstanding equity of Endosense. The terms also provide for an additional cash payment of up to $161 million, which is contingent upon both the achievement and timing of a regulatory milestone.
St. Jude Medical said, except for acquisition-related expenses, the deal does not impact its outlook for 2013 consolidated earnings per share.
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org